RxDoctor Payments DataLook up a doctor →

Kimathi Blackwood, MD

Nephrology · Macon, GANPI 1609071448

Payments from drug & device makers

$64,004in general payments, 2019–2025

Across 451 payments — averaging $141.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$52K
  • Calliditas Therapeutics US Inc.$4K
  • AstraZeneca$756
  • OPKO Pharmaceuticals, LLC$609
  • Bayer$608
  • Otsuka America Pharmaceutical, Inc.$600
  • plus $5K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)161$52,177
Calliditas Therapeutics US Inc.16$4,416
AstraZeneca(2 entities)26$756
OPKO Pharmaceuticals, LLC45$609
Bayer22$608
Otsuka America Pharmaceutical, Inc.22$600
Mallinckrodt Hospital Products Inc.11$500
Travere Therapeutics, Inc.10$498
GSK12$498
Novo Nordisk11$471
Akebia Therapeutics Inc18$435
Aurinia Pharma U.S., Inc.16$389
ANI Pharmaceuticals, Inc.10$309
Vifor Pharma, Inc.11$289
Fresenius USA Marketing, Inc.11$208
Novartis8$141
Johnson & Johnson2$133
Outset Medical Inc1$125
Bard Peripheral Vascular, Inc.1$114
Ardelyx, Inc.4$86
Alnylam Pharmaceuticals Inc.3$77
Boehringer Ingelheim4$75
Leadiant Biosciences, Inc.2$58
Daiichi Sankyo Inc.3$56
Baxter Healthcare2$48
Merck3$43
Mallinckrodt Enterprises LLC2$42
Apellis Pharmaceuticals, Inc.2$36
Otsuka Pharmaceutical Development & Commercialization, Inc.2$35
Portola Pharmaceuticals, LLC1$26
Amicus Therapeutics, Inc.1$21
Rockwell Medical, Inc.1$21
Scpharmaceuticals Inc.1$20
Abbott1$20
Sanofi1$19
Takeda Pharmaceuticals U.S.A., Inc.1$18
E.r. Squibb & Sons, L.L.C.1$12
Medtronic1$12
Theracosbio, LLC1$6

How this compares

$64,004 in reported general payments places this provider in the 85th percentile of 388 nephrology providers in Georgia.

See all nephrology providers in Georgia →

Medicare billing

Part B allowed, 2024
$194,953
Medicare patients
325
Services billed
1,155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Macon

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →